Filing Details

Accession Number:
0001104659-20-129005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-24 16:09:47
Reporting Period:
2020-11-20
Accepted Time:
2020-11-24 16:09:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182633 Md Melvin Sharoky 700 Us Highway 202/206
Bridgewater NJ 08807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-20 4,000 $38.98 5,900 No 4 S Indirect Held by Baby Gator LLC
Common Stock Disposition 2020-11-23 4,000 $39.11 232,890 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Baby Gator LLC
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,714 Indirect Held by The Sharoky Family Foundation, Inc.
Footnotes
  1. This is the weighted average sales price representing 4,000 shares sold at prices ranging from $38.92 to $39.05 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  2. The Reporting Person is a managing member of Baby Gator LLC.
  3. This is the weighted average sales price representing 4,000 shares sold at prices ranging from $39.04 to $39.17 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  4. The Reporting Person is Chairman of The Sharoky Family Foundation, Inc. and is one of three individuals who currently share voting and investment power over the shares held by The Sharoky Family Foundation, Inc. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.